Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 758

Sort by

Sort Order Select

Journal Articles

Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood. 2020;135(7):472-490.

Blood (2020) 135 (25): 2325.

https://doi.org/10.1182/blood.2020006529

Published: 2020

Journal Articles

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

Emily Molina, DO, MSPH, Gursharon Sanghera, MD, Patrick Hanley, MD, Rafat Ahmed, MD

Blood (2019) 134 (Supplement_1): 4900.

https://doi.org/10.1182/blood-2019-126200

Published: 2019

Journal Articles

Trial in Progress: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Nichola Cooper, MD MRCP, Isabel Gorham, BS RN, Ann M. Lowe, MD, Robert P. Numerof, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 4800.

https://doi.org/10.1182/blood-2019-126544

Published: 2019

Journal Articles

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Megan C. Brown, MD, Michael H. White, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 627.

https://doi.org/10.1182/blood-2019-127258

Published: 2019

Journal Articles

Onset of Regulatory B Cells Occurs at Initial Stage of B Cell Dysfunction in Multiple Myeloma

Zhongqing Zou, Tingting Guo, Jian Cui, Li Zhang, Ling Pan

Blood (2019) 134 (Supplement_1): 1780.

https://doi.org/10.1182/blood-2019-128703

Published: 2019

Journal Articles

Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience

Hasmik Nazaryan, Yang Liu, MS, Emily Sirotich, BS, Joanne M Duncan, MSc, Donald M. Arnold, MD

Blood (2019) 134 (Supplement_1): 2120.

https://doi.org/10.1182/blood-2019-128336

Published: 2019

Journal Articles

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Robert J Klaassen, MD FRCPC, Julia Y. Kinahan, MDcal Student, Johann M. I. Graham, MDcal Student, Yamilée V. Hébert, MDcal Student, Katie O'Hearn, MSc Human Kinetics

Blood (2019) 134 (Supplement_1): 2180.

https://doi.org/10.1182/blood-2019-127248

Published: 2019

Journal Articles

Romiplostim Improves Platelet Recovery after UCB Transplant

Georgios E. Christakopoulos, MD, Todd E. DeFor, MS, Stefanie M Hage, RN, John E. Wagner, MD, Michael A. Linden, MD PhD, Claudio G Brunstein, MD PhD, Nelli Bejanyan, MD, Michael R Verneris, MD, Angela R. Smith, MD MS

Blood (2019) 134 (Supplement_1): 1979.

https://doi.org/10.1182/blood-2019-125424

Published: 2019

Journal Articles

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

Michelle Neier, MD, Michele P. Lambert, MD, Rachael F. Grace, MD, Kerry Hege, MD, Stephanie Chiu, MPH, Julianne Thompson, Robert J Klaassen, MD FRCPC

Blood (2019) 134 (Supplement_1): 2174.

https://doi.org/10.1182/blood-2019-125686

Published: 2019

Journal Articles

A Systematic Review and Meta-Analysis of Cardio-Vascular Side Effects with Fostamatinib a Spleen Tyrosine Kinase Inhibitor

Muhammad Zain Farooq, MD MBBS, Prasanth Lingamaneni, Saira Farid, MD, Muhammad Saad Farooq, MBBS, Ishaan Vohra, MD, Asim Tameez ud din, MD, Ankit Mangla, MBBS,MD

Blood (2019) 134 (Supplement_1): 3465.

https://doi.org/10.1182/blood-2019-132151

Published: 2019

Journal Articles

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

Karthik Gnanapandithan, MD MS, Prakash Kharel, MD, Alyssa Grimshaw, MSLIS, Smith Giri, MBBS

Blood (2019) 134 (Supplement_1): 3606.

https://doi.org/10.1182/blood-2019-132203

Published: 2019

Journal Articles

The Role of Monitoring Complement Levels in Catastrophic Antiphospholipid Syndrome: A Case Series of 4 Patients

Lauren M Panebianco, MD, Teresa Gentile, MD PhD

Blood (2019) 134 (Supplement_1): 4872.

https://doi.org/10.1182/blood-2019-128297

Published: 2019

Journal Articles

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Kerry A. Rogers, MD, Michael A. Boxer, MD, Michael Y. Choi, MD, Richy Agajanian, MD, Donald M. Arnold, MD, Catherine M. Broome, MD, Joshua J. Field, MD, Irina Murakhovskaya, MD, Donna Chow, Robert P. Numerof, PhD, Hanzhe Zheng, PhD, Sandy Tong, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 3518.

https://doi.org/10.1182/blood-2019-126509

Published: 2019

Journal Articles

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Blood (2019) 134 (Supplement_1): 3000.

https://doi.org/10.1182/blood-2019-126744

Published: 2019

Journal Articles

Autoantibody Mediated Desialylation Impairs Human Thrombopoiesis and Platelet Life Span

Irene Marini, Jan Zlamal, Lisann Pelzel, Wolfgang Bethge, Christoph Faul, MD, Ursula Holzer, PD Dr. MD, Karina Althaus, Tamam Bakchoul, Prof. Dr.

Blood (2019) 134 (Supplement_1): 2346.

https://doi.org/10.1182/blood-2019-131725

Published: 2019

Journal Articles

Next Generation Sequencing-Based Characterization of T Cell Receptor Repertoire of Patients with Immune Thrombocytopenia

Panpan Han, Xiaoqing You, Clara Lo, MD, Liwen Xu, Haiyu Zhang, James L Zehnder, Bing Melody Zhang

Blood (2019) 134 (Supplement_1): 2347.

https://doi.org/10.1182/blood-2019-127590

Published: 2019

Journal Articles

A Clinical Prediction Score for Course of Disease in Newly Diagnosed Childhood Immune Thrombocytopenia

David Schmidt, MD MSc, Katja M.J. Heitink-Pollé, MD PhD, C. Ellen van der Schoot, MD PhD, Leendert Porcelijn, MD, Gestur Vidarsson, PhD, Marrie Bruin, MD PhD, Johanna G. van der Bom, MD PhD, Masja De Haas, MD PhD

Blood (2019) 134 (Supplement_1): 2376.

https://doi.org/10.1182/blood-2019-130391

Published: 2019

Journal Articles

Platelet Dysfunction Detected Using Rotational Thromboelastometry (ROTEM) in Severely Thrombocytopenic Patients with a Bleeding Phenotype

Philip Young-Ill Choi, BSc, MBBS, PhD, Sarah Hicks, Elizabeth E. Gardiner, PhD, Philip Crispin, MBBS, FRACP, FRCPA, James Slade, BN, GCCaN, MNNP, James D'Rozario, MBBS, FRACP, FRCPA, Christopher Parish, PhD, Lucy Coupland, PhDBSc,RN

Blood (2019) 134 (Supplement_1): 2357.

https://doi.org/10.1182/blood-2019-132232

Published: 2019

Journal Articles

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Waleed Ghanima, MD PhD, Marc Michel, Abderrahim Khelif, Bernadette Darne, Pal André Holme, PhDMD

Blood (2019) 134 (Supplement_1): 2358.

https://doi.org/10.1182/blood-2019-126975

Published: 2019

Journal Articles

Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias

Emma Westermann-Clark, MD, Krisztian Csomos, PhD, Rachel Cruz Nieves, Other, Cristina Meehan, BS, Boglarka Ujhazi, BS, Maryssa Ellison, Jennifer Lynne Root Mayer, MD, Jonathan Metts, MD, Marisol Betensky, MDMPH, Panida Sriaroon, MD, Irmel Ayala, MD, Jolan Walter, MD PhD

Blood (2019) 134 (Supplement_1): 2328.

https://doi.org/10.1182/blood-2019-130289

Published: 2019

NARROW

Miltiadous O, Hou M, Bussel JB. Identifying and treating refractory ITP: difficulty in diagnosis and role of combination treatment. Blood. 2020;135(7):472-490.

A Rare Presentation of Acute Immune Thrombocytopenia, Refractory to First Line Therapy, Despite Euthyroid State

Trial in Progress: Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Global Study of Fostamatinib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia

Obtaining a Von Willebrand Evaluation at Time of Acute Heavy Menstrual Bleeding Presentation Leads to Overestimation of Von Willebrand Levels

Onset of Regulatory B Cells Occurs at Initial Stage of B Cell Dysfunction in Multiple Myeloma

Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience

Patient-Reported Outcome Measures (PROMs) in Pediatric Non-Malignant Hematology: A Systematic Review

Romiplostim Improves Platelet Recovery after UCB Transplant

The Effect of "Pathway" to Diagnosis for Childhood ITP on Caregiver Quality of Life at Time of Diagnosis

A Systematic Review and Meta-Analysis of Cardio-Vascular Side Effects with Fostamatinib a Spleen Tyrosine Kinase Inhibitor

Hematologic Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Systematic Review of Case-Reports and Case-Series

The Role of Monitoring Complement Levels in Catastrophic Antiphospholipid Syndrome: A Case Series of 4 Patients

Fostamatinib, a Spleen Tyrosine Kinase (SYK) Inhibitor, for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia (wAIHA): Final Results of the Phase 2, Multicenter, Open-Label Study

Long Term Effects of Eltrombopag Treatment Versus Placebo for Low-Risk Myelodysplastic Syndromes with Thrombocytopenia (EQoL-MDS): Interim Results of a Single-Blind, Randomised, Controlled, Phase 2 Superiority Trial

Autoantibody Mediated Desialylation Impairs Human Thrombopoiesis and Platelet Life Span

Next Generation Sequencing-Based Characterization of T Cell Receptor Repertoire of Patients with Immune Thrombocytopenia

A Clinical Prediction Score for Course of Disease in Newly Diagnosed Childhood Immune Thrombocytopenia

Platelet Dysfunction Detected Using Rotational Thromboelastometry (ROTEM) in Severely Thrombocytopenic Patients with a Bleeding Phenotype

Rituximab Yielded a Significantly Longer Response Compared to Placebo in Steroid Free Population - a Post Hoc Analysis of the Ritp Study

Identifying Primary Immune Deficiencies in Patients with Autoimmune Cytopenias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only